Bioelectronica is a research-stage biotechnology company building intelligent, digital tools for drug discovery, cell screening and cell sorting.
After successfully using electronics to measure single molecules of DNA in a High Throughput Next Gen Sequencing system at a biotech startup acquired by a Big Pharma corporation, our founder, Roger Chen, started Bioelectronica to engineer single-cell and protein detection.
We have a seasoned team of world-class technical talent in the areas of systems engineering, cell biology, and wet-chemistry, with a long history of working together to create value for our shareholders.
By uniquely coalescing chemistry and engineering, we have developed an alternative to analytical tools like fluorescence activated cell sorting along with an alternative to liquid handling robots and other traditional methods.
More Info